脊髓电刺激治疗慢性疼痛的荟萃分析方法学与统计学特征:系统综述
结果显示仅3篇高质量、3篇低质量、19篇极低质量;发表年份与质量无关,期刊影响因子与质量正相关。
要点
- 多数脊髓电刺激治疗慢性疼痛的荟萃分析方法学质量极低。
- 期刊影响因子较高与AMSTAR-2质量较高相关。
- 仅3篇研究有足够把握度(>80%)拒绝原假设。
核心结论
- 大多数关于脊髓电刺激治疗慢性疼痛的荟萃分析AMSTAR-2质量为极低。
主要发现
- 发表年份与AMSTAR-2总体质量无关联(β 0.043;95%CI -0.008至0.095;p=0.097)。
- 影响因子与AMSTAR-2总体质量有关联(β 0.108;95%CI 0.044至0.172;p=0.002)。
- 效应量与AMSTAR-2总体质量无关联(β -0.168;95%CI -0.518至0.183;p=0.320)。
- 根据把握度分析,3篇研究有足够把握度(>80%)拒绝原假设,其余研究把握度不足(<80%)。
关键数值与推荐
- AMSTAR-2质量分级:高质量3篇、低质量3篇、极低质量19篇。
- 影响因子与AMSTAR-2总体质量的回归系数β 0.108(95%CI 0.044至0.172;p=0.002)。
- 发表年份与AMSTAR-2总体质量的回归系数β 0.043(95%CI -0.008至0.095;p=0.097)。
- 效应量与AMSTAR-2总体质量的回归系数β -0.168(95%CI -0.518至0.183;p=0.320)。
临床怎么用
- 临床解读脊髓电刺激治疗慢性疼痛的荟萃分析时,应警惕多数研究方法学质量极低。
- 未来荟萃分析应遵循AMSTAR-2清单条目以提高质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A growing number of meta-analyses (MA) have investigated the use of spinal cord stimulation (SCS) as a treatment modality for chronic pain. The quality of these MAs has not been assessed by validated appraisal tools. OBJECTIVE: To examine the methodological characteristics and quality of MAs related to the use of SCS for chronic pain syndromes. EVIDENCE REVIEW: An online literature search was conducted in Ovid MEDLINE(R), Ovid EMBASE, Ovid Cochrane Database of Systematic Reviews, and Scopus databases (January 1, 2000 through June 30, 2023) to identify MAs that investigated changes in pain intensity, opioid consumption, and/or physical function after SCS for the treatment of chronic pain. MA quality was assessed using A Measurement Tool to Assess Systematic Reviews (AMSTAR-2) critical appraisal tool. FINDINGS: Twenty-five MAs were appraised in the final analysis. Three were considered "high" quality, three "low" quality, and 19 "critically low" quality, per the AMSTAR-2 criteria. There was no association between the publication year and AMSTAR-2 overall quality (β 0.043; 95% CI -0.008 to 0.095; p=0.097). There was an association between the impact factor and AMSTAR-2 overall quality (β 0.108; 95% CI 0.044 to 0.172; p=0.002), such that studies published in journals with higher impact factors were associated with higher overall quality. There was no association between the effect size and AMSTAR-2 overall quality (β -0.168; 95% CI -0.518 to 0.183; p=0.320).According to our power analysis, three studies were adequately powered (>80%) to reject the null hypothesis, while the remaining studies were underpowered (<80%). CONCLUSIONS: The study demonstrates a critically low AMSTAR-2 quality for most MAs published on the use of SCS for treating chronic pain. Future MAs should improve study quality by implementing the AMSTAR-2 checklist items. PROSPERO REGISTRATION NUMBER: CRD42023431155.
引用
- Kleppel DJ, Copeland R, Hussain N, et al. Methodological and statistical characteristics of meta-analyses on spinal cord stimulation for chronic pain: a systematic review. Reg Anesth Pain Med. 2025. PMID: 38388015. doi:10.1136/rapm-2023-105249
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。